Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans

Eli Lilly announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19. This investigational medicine, referred to as LY-CoV555...

LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients With U.S. Research Trials

LabCorp , a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, has created COVID-19 Clinical Trial Connect in the U.S.

Biocair Transports Plasmids For COVID-19 Research in South Africa

Biocair, a global specialist in life sciences logistics, was selected to transport time-critical plasmids from the USA to the Africa Health Research Institute (AHRI) in Durban, South Africa....

Greenphire Launches New Clinical Trial Budget Build and Negotiation Solution, EnvisiX

Greenphire, the global leader in financial lifecycle management for clinical trials, announced the launch of EnvisiX to address the budgeting challenges experienced by global sponsors and CROs...

Thermo Fisher Scientific Announces Collaboration to Provide Access to Deep Learning Tools for Discovery and Targeted Proteomics

Thermo Fisher Scientific announce an exclusive license agreement to develop and commercialize deep learning tools for proteomics, making MSAID's Prosit-derived framework widely accessible to proteomics...

Honeywell Expedites Development and Production of Vital Vaccines and Medical Therapies with Fast Track Automation

Honeywell announced Fast Track Automation, a combination of proprietary technology innovations for the life sciences industry that enables vital vaccines, treatments and therapies to move from regulatory...

Takeda Announces Phase 2 Trial of Pevonedistat Plus Azacitidine in Patients with Higher-Risk MDS

Takeda Pharmaceutical Company Limited announced the results of the Phase 2 Pevonedistat-2001 trial will be presented during oral sessions at the virtual 56th American Society of Clinical Oncology...

Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment

Merck announced their collaboration on a clinical trial program designed to investigate the efficacy and safety of anti-PD-1 mAb toripalima in combination with Cetuximab as a treatment for recurrent...